This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Buy American: 5 Stocks to Escape the Eurozone Crisis

Express Scripts

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Finally, there's Express Scripts (ESRX - Get Report), the largest pharmacy benefit manager in the U.S. ESRX essentially acts as a middle man between drug companies and pharmacies, administering more than a billion (Medco merger-adjusted) prescriptions each year. Express Scripts benefits from economies of scale -- it focuses on controlling costs by administering drug benefits, and taking a small margin for its trouble.

While middleman roles are typically fraught with risk, Express Scripts showed investors just how strong its business was this summer when its feud with Walgreen (WAG) ended in the two companies' relationship. The split didn't last long. Ultimately, Walgreen suffered from the move when it lost patient volume, and it's likely that it yielded to Express Scripts' bigger reimbursement demands. That public scuffle is likely to be a warning to the other firms that pharmacy benefit managers deal with.

>>4 Biotech Stocks Under $10 With Relative Strength

Because Express Scripts operates within the U.S. healthcare system, it earns all of its revenues here at home. The recently upheld healthcare reform mandate is likely to provide a tailwind to ESRX when its pool of potential customers grows.

As of the most recently reported quarter, Express Scripts was one of SAC Capital's holdings and also shows up in George Soros' portfolio.

To see these names in action, check out the Buy American 2012 Portfolio on Stockpickr.

-- Written by Jonas Elmerraji in Baltimore.


Follow Stockpickr on Twitter and become a fan on Facebook.
At the time of publication, author had no positions in stocks mentioned.

Jonas Elmerraji is the editor and portfolio manager of the Rhino Stock Report, a free investment advisory that returned 15% in 2008. He is a contributor to numerous financial outlets, including Forbes and Investopedia, and has been featured in Investor's Business Daily, in Consumer's Digest and on
6 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
LTD $0.00 0.00%
CVC $31.68 0.00%
DUK $79.04 0.00%
DLTR $76.56 0.00%
ESRX $67.84 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs